Eprodisate slows the progression of renal disease in patients with AA amyloidosis
- PMID: 17876351
- DOI: 10.1038/ncpneph0615
Eprodisate slows the progression of renal disease in patients with AA amyloidosis
Comment on
-
Eprodisate for the treatment of renal disease in AA amyloidosis.N Engl J Med. 2007 Jun 7;356(23):2349-60. doi: 10.1056/NEJMoa065644. N Engl J Med. 2007. PMID: 17554116 Clinical Trial.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources